Alignment Healthcare, Inc.(ALHC)Earnings, Financials & Key RatiosAlignment Healthcare, Inc. (ALHC) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the company has achieved a positive free cash flow of $121.3 million, the persistent $14.0 million quarterly stock-based compensation expense and the $997.6 million accumulated deficit warrant a cautious approach.
Alignment Healthcare, Inc. (ALHC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Alignment Healthcare, Inc. (ALHC) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $0.05vs $0.01+400.0% | $1.2Bvs $1.2B+1.4% |
| Q1 2026 | Feb 26, 2026 | $0.05vs $0.15+66.7% | $1.0Bvs $1.0B+0.9% |
| Q4 2025 | Oct 30, 2025 | $0.02vs $0.01+300.0% | $994Mvs $981M+1.3% |
| Q3 2025 | Jul 30, 2025 | $0.07vs $0.07+200.0% | $1.0Bvs $960M+5.8% |
Recent stock market news and headlines for Alignment Healthcare, Inc. (ALHC)
Konowiecki sold 25,000 shares for a transaction value of $550,000 at around $22.00 per share on June 18, 2026. The sale represented 2.1% of his direct holdings, with 1,153,816 shares remaining post-transaction.
ALHC, AGX, AGYS and CIEN make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.
Key metrics vs top competitors for Alignment Healthcare, Inc. (ALHC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $24.05 | $4.91B | -6500.00 | 46.06% | -0.02% | -0.52% | — | |
| $66.12 | $32.65B | -4.85 | 19.44% | -3.25% | -28.6% | — | |
| $232.90 | $12.13B | 26.11 | 11.75% | 0.42% | 4.44% | — | |
| $104.33 | $133.12B | 75.06 | 7.85% | 0.72% | 3.86% | — | |
| $394.62 | $47.38B | 40.10 | 10.06% | 0.82% | 6.17% | — | |
| $418.85 | $90.96B | 16.67 | 12.62% | 2.62% | 11.92% | — |
Alignment Healthcare, Inc. (ALHC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Alignment Healthcare, Inc. (ALHC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 30, 2026·SEC
Mar 4, 2026·SEC
Feb 26, 2026·SEC
Get notified when ALHC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Alignment Healthcare, Inc. (ALHC) stock FAQ — growth, dividends, profitability & financials explained
Alignment Healthcare, Inc. (ALHC) reported $4.26B in revenue for fiscal year 2025. This represents a 462% increase from $757.0M in 2019.
Alignment Healthcare, Inc. (ALHC) grew revenue by 46.1% over the past year. This is strong growth.
Yes, Alignment Healthcare, Inc. (ALHC) is profitable, generating $19.8M in net income for fiscal year 2025 (-0.0% net margin).
Alignment Healthcare, Inc. (ALHC) has a return on equity (ROE) of -0.5%. Negative ROE indicates the company is unprofitable.
Alignment Healthcare, Inc. (ALHC) generated $236.6M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
